Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Sep;154(3):558-564.
doi: 10.1002/ijgo.13652. Epub 2021 Mar 24.

Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial

Mohammed K Ali  1 , Samar M Emam  1 , Mahmoud A Abdel-Aleem  1 , Ahmed M A Sobh  1
Affiliations
Randomized Controlled Trial

Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial

Mohammed K Ali et al. Int J Gynaecol Obstet. 2021 Sep.

Retraction in

  • Retraction.
    [No authors listed] [No authors listed] Int J Gynaecol Obstet. 2024 May;165(2):842. doi: 10.1002/ijgo.15450. Epub 2024 Feb 28. Int J Gynaecol Obstet. 2024. PMID: 38419152

Abstract

Objective: To compare the effectiveness and safety of repeat misoprostol versus expectant management in women with first-trimester incomplete miscarriage who have been initially treated with misoprostol.

Methods: The study was an open-labeled randomized controlled trial including women with an incomplete first-trimester miscarriage after administration of misoprostol. The participants were randomly assigned to vaginal misoprostol or expectant management using a computer-generated table of random numbers. The primary outcome was the number of women with a complete miscarriage at 1 week.

Results: Eighty-eight women (44 women in each group) were analyzed. The rate of complete miscarriage at 1 week was significantly higher in the misoprostol group than the expectant management group-29 (69.0%) versus 7 (16.7%) (P < 0.001), respectively. Women in the misoprostol group were more satisfied (7.00 ± 0.77 vs 4.57 ± 1.61, P < 0.001) but reported more pain (7.95 ± 1.85 vs 5.26 ± 1.08, P < 0.001) than women in the expectant group. The misoprostol group reported more adverse effects than the expectant management group (P < 0.001).

Conclusion: In women with an incomplete first-trimester miscarriage who were initially treated with misoprostol, repeat administration of misoprostol was more effective than expectant management for achieving complete miscarriage at 1 week. However, misoprostol was associated with more adverse effects.

Registration site and number: Clinicaltrials.gov: NCT03148561.

Keywords: incomplete miscarriage; misoprostol; prostaglandins; retained products of conception.

PubMed Disclaimer

References

REFERENCES

    1. Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017;1:CD007223.
    1. Gebretsadik A. Factors associated with management outcome of incomplete abortion in Yirgalem General Hospital, Sidama Zone, Southern Ethiopia. Obstet Gynecol Int. 2018;2018:3958681.
    1. Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expectant management of spontaneous first-trimester miscarriage: prospective validation of the ‘2-week rule'. Ultrasound Obstet Gynecol. 2010;35(2):223-227.
    1. Ryu S, Baek HW, Lee I, et al. Operative hysteroscopy-assisted pregnancy termination after failed surgical abortion in missed abortion of woman with complete septate uterus. Obstet Gynecol Sci. 2020;63(1):102-106.
    1. Chowdhury M, Rahman D. Surgical management of incomplete abortion by manual vacuum aspiration (MVA). Mymensingh Med J. 2019;28(4):900-905.

Publication types

Substances

Associated data

LinkOut - more resources